Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSX- V:SWA) is pleased to advise that it has executed a non-binding...
Read moreCybercrime is a growing concern, and it’s estimated that the annual cost of fighting cyber crime will reach US$10.5 trillion...
Read moreFrom established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to...
Read moreChina’s Zijin Mining Group (OTC Pink:ZIJMF,SHA:601899) is reportedly in negotiations to acquire a potential controlling interest in Zangge Mining (SZSE:000408),...
Read moreIron prices started off strong at the beginning of 2024, but have since dropped steeply to two-year lows. Market watchers...
Read moreInvestor Insight Radiopharm Theranostics represents a promising investment opportunity in the rapidly growing field of radiopharmaceuticals, leveraging its innovative technology...
Read moreCybercrime is a growing concern, and it’s estimated that the annual cost of fighting cyber crime will reach US$10.5 trillion...
Read moreMicron Technology (NASDAQ:MU) announced a US$7 billion investment to build a high-bandwidth memory (HBM) chip-packaging facility in Singapore to meet...
Read moreCobalt prices started 2024 trading at the US$29,151.50 per metric ton level, the highest price point the battery metal achieved...
Read moreLead prices rode a wave of volatility in 2024 as global economic uncertainty continued to wreak havoc on metals markets....
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved